All sponsors

Pharmazz, Inc.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS6
PHASE 3 / 2-33
RECRUITING3
READOUTS ≤12 MONTHS3
READOUT SLIPPED >6 MO100%

Delay Index: of 5 active trials registered more than a year ago, 5 have moved their primary completion (readout) date by more than 6 months since first registration (median +53.0 months). See all sponsors →

Open Pharmazz, Inc. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
Normal Saline along with standard treatment
NCT04054414
P2RecruitingAcute Spinal Cord Injury402026-06 (+72 mo)
Normal Saline along with standard treatment
NCT05514340
P2RecruitingHypoxic-Ischemic Encephalopathy; Neonatal Asphyxia402026-11 (+25 mo)
RESPECT-ETB
NCT05691244
P3RecruitingAcute Ischemic Stroke; Cerebral Stroke5142027-09 (+30 mo)
Normal Saline
NCT05241067
P2Not yet recruitingAcute Respiratory Distress Syndrome (ARDS)802027-10-31 (+53 mo)
RESTORE-TBI
NCT07861126
P3Not yet recruitingTraumatic Brain Injury2142028-02
Normal Saline
NCT05251181
P3Not yet recruitingHypovolemic Shock4302028-10 (+55 mo)